119 related articles for article (PubMed ID: 26637775)
1. Molecularly targeted therapies for acute myeloid leukemia.
Stein EM
Hematology Am Soc Hematol Educ Program; 2015; 2015():579-83. PubMed ID: 26637775
[TBL] [Abstract][Full Text] [Related]
2. New Targeted Agents in Acute Myeloid Leukemia: New Hope on the Rise.
Bohl SR; Bullinger L; Rücker FG
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018543
[TBL] [Abstract][Full Text] [Related]
3. Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in
Shih AH; Meydan C; Shank K; Garrett-Bakelman FE; Ward PS; Intlekofer AM; Nazir A; Stein EM; Knapp K; Glass J; Travins J; Straley K; Gliser C; Mason CE; Yen K; Thompson CB; Melnick A; Levine RL
Cancer Discov; 2017 May; 7(5):494-505. PubMed ID: 28193779
[TBL] [Abstract][Full Text] [Related]
4. Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies.
Lee E; Koh Y; Hong J; Eom HS; Yoon SS
J Korean Med Sci; 2021 Apr; 36(13):e85. PubMed ID: 33821592
[TBL] [Abstract][Full Text] [Related]
5. Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia
Vignal N; Kelly L; Lengline E; Cabannes-Hamy A; Siavellis J; Ghez D; Sauvageon H; Braun T; Jacqz-Aigrain E; Kohn M; Rousselot P; Puissant A; Raffoux E; Mourah S; Goldwirt L
Haematologica; 2023 Sep; 108(9):2531-2534. PubMed ID: 36794507
[No Abstract] [Full Text] [Related]
6. Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib.
Schaab C; Oppermann FS; Klammer M; Pfeifer H; Tebbe A; Oellerich T; Krauter J; Levis M; Perl AE; Daub H; Steffen B; Godl K; Serve H
Leukemia; 2014 Mar; 28(3):716-9. PubMed ID: 24247654
[No Abstract] [Full Text] [Related]
7. Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia.
Kurtz SE; Eide CA; Kaempf A; Mori M; Tognon CE; Borate U; Druker BJ; Tyner JW
Leukemia; 2018 Sep; 32(9):2025-2028. PubMed ID: 30082821
[No Abstract] [Full Text] [Related]
8. Emerging therapies for acute myeloid leukemia.
Saygin C; Carraway HE
J Hematol Oncol; 2017 Apr; 10(1):93. PubMed ID: 28420416
[TBL] [Abstract][Full Text] [Related]
9. Advances in targeted therapy for acute myeloid leukaemia.
Kayser S; Levis MJ
Br J Haematol; 2018 Feb; 180(4):484-500. PubMed ID: 29193012
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the understanding and treatment of acute myeloid leukemia.
Watts J; Nimer S
F1000Res; 2018; 7():. PubMed ID: 30135719
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeting in acute myeloid leukemia.
Lim SH; Dubielecka PM; Raghunathan VM
J Transl Med; 2017 Aug; 15(1):183. PubMed ID: 28851395
[TBL] [Abstract][Full Text] [Related]
12. Emerging therapies for acute myeloid leukemia: translating biology into the clinic.
Kavanagh S; Murphy T; Law A; Yehudai D; Ho JM; Chan S; Schimmer AD
JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931762
[TBL] [Abstract][Full Text] [Related]
13. Management of toxicities associated with targeted therapies for acute myeloid leukemia: when to push through and when to stop.
Wang ES; Baron J
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):57-66. PubMed ID: 33275692
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Mechanisms in Leukemias and Lymphomas.
Duy C; Béguelin W; Melnick A
Cold Spring Harb Perspect Med; 2020 Dec; 10(12):. PubMed ID: 32014848
[TBL] [Abstract][Full Text] [Related]
15. [Isocitrate dehydrogenase mutation in acute myeloid leukemia].
Zhang Y; Yang L
Zhonghua Xue Ye Xue Za Zhi; 2015 Jan; 36(1):82-4. PubMed ID: 25641158
[No Abstract] [Full Text] [Related]
16. Molecularly targeted therapy in acute myeloid leukemia.
Gill H; Leung AY; Kwong YL
Future Oncol; 2016 Mar; 12(6):827-38. PubMed ID: 26828965
[TBL] [Abstract][Full Text] [Related]
17. Emerging therapeutic drugs for AML.
Stein EM; Tallman MS
Blood; 2016 Jan; 127(1):71-8. PubMed ID: 26660428
[TBL] [Abstract][Full Text] [Related]
18. Moving toward targeted therapies in acute myeloid leukemia.
Gao W; Estey E
Clin Adv Hematol Oncol; 2015 Nov; 13(11):748-54. PubMed ID: 27058701
[TBL] [Abstract][Full Text] [Related]
19. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.
Grimwade D; Ivey A; Huntly BJ
Blood; 2016 Jan; 127(1):29-41. PubMed ID: 26660431
[TBL] [Abstract][Full Text] [Related]
20. FLT3 Inhibitors for Treating Acute Myeloid Leukemia.
Hassanein M; Almahayni MH; Ahmed SO; Gaballa S; El Fakih R
Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):543-549. PubMed ID: 27450971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
